About the Authors
- Isabel Fofana
-
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France
- Fei Xiao
-
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France
- Christine Thumann
-
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France
- Marine Turek
-
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France
- Laetitia Zona
-
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France
- Rajiv G. Tawar
-
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France
- Fritz Grunert
-
Affiliation Aldevron GmbH, Freiburg, Germany
- John Thompson
-
Affiliation Aldevron GmbH, Freiburg, Germany
- Mirjam B. Zeisel
-
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France
- Thomas F. Baumert
-
* E-mail: Thomas.Baumert@unistra.fr
Affiliations Inserm, U1110, Institute of Virology, Strasbourg, France, University of Strasbourg, Strasbourg, France, Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Competing Interests
FG and JT are employees of Aldevron GmbH, a company who participated in the development of the anti-CD81 antibodies within a collaborative research agreement with the University of Strasbourg and Inserm. FG and JT have been notified regarding PLOS ONE policies and stated that their participation does not alter their adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: TFB. Performed the experiments: IF FX CT MT LZ RGT FG JT MBZ TFB. Analyzed the data: IF FX CT MT LZ RGT FG JT MBZ TFB. Wrote the paper: IF MBZ TFB.